Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Chervon Names Peter J. Carlson Director of Sales for Strategic Accounts
-
Chervon Names Daniel L. Abbott Director of Sales - Western U.S.A.
-
Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary
-
LiveOne (NASDAQ:LVO) Subsidiary PodcastOne (NASDAQ:PODC) Launches Multi-Year Distribution, Content and Marketing Partnership with National Military Podcast Day
-
Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
-
Breaker Launches Newsletter MCP + API for AI Workflows and RealClick™ for Verified Metrics
-
Peer To Peer Network Launches PTOP Intelligence Lab Website Featuring MOBICARD(TM) and Synaptic Quant(TM)
-
TRWD Signs First U.S. Licensing Agreement, Accelerating Recurring Revenue Expansion and 100+ Venue Strategy
-
Hypha Labs Targets Disruptive Mushroom Active Ingredient Production
-
GameSquare to Present at Upcoming Investor Conferences
-
Securitas Technology Releases 2027 Global Technology Outlook Report
-
Yanmar America Finance Selects Vero Technologies to Support the Launch of Its Captive Floorplan Finance Program
-
Behind on Back Taxes? Clear Start Tax Explains the IRS Program Thousands Are Using to Cut What They Owe
-
International Brain Health Coalition Launches to Put Proven Strategies Into Action
-
EPAM Unveils New Frontier AI Service, Bridging the Enterprise Intelligence Gap for GenAI and Autonomous Agents
-
Once Upon a Farm Expands Kids Portfolio With Organic Electrolyte Pouches
-
Mary Kay Introduces the K-Beauty Texture Edit
-
Corcel Announces Upsized Non-Brokered Private Placement
-
PharmaTher Outlines Corporate Strategy and Upcoming Milestones; Launches New Corporate Website and Rebrands PERSONALIZ3D as M3DICINES
-
Telescope Innovations Reports 60% Revenue Growth in Preliminary Unaudited Fiscal Year 2026 Results
-
Homeland Assays Confirm Historical Drilled Uranium-Vanadium Grades at Cross Bones
-
Solidus Labs Announces Participation in the PREDICT Conference
-
Cannara Expands International Supply Agreement with Curaleaf
-
FTC Solar Announces Waiver and Amendment to Credit Agreement
-
Ardelyx to Present New Data on Hyperphosphatemia Management at ASN Kidney Week 2026
-
New Peer-Reviewed Study Demonstrates Amprion's Seed Amplification Assay Can Differentiate Multiple System Atrophy from Parkinson's Disease Using Skin Biopsy Samples
-
MaisonCrest Launches New Online Destination for Luxury Furniture and Décor
-
Thunder Mountain Gold Strengthens Board with Appointment of Veteran Mining Executive Ron Clayton
-
Extendicare Announces Timing of 2026 Third Quarter Results and Conference Call
-
Mayo Lake Minerals Announces Non-Brokered Private Placement of Units for up to $700,000
-
Zscaler Collaborates with IBM and Red Hat to Protect Private Applications from Frontier AI-Powered Threats
-
Dillard’s Introduces Hadley Greene x Gianni Bini Fall 2026 Collaboration
-
Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)
-
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer
-
Benitec Biopharma Announces Regulatory Update Following Type C Meeting with FDA for BB-301 Pivotal Study
-
Axero Recognized in the 2026 Gartner® Magic Quadrant™ for Intranet Packaged Solutions for the Third Consecutive Year
-
Aeroplan Members Can Multiply Their Impact for Children Travelling for Essential Medical Care During Points Matching Week
-
CoreCivic Announces 2026 Third Quarter Earnings Release and Conference Call Dates
-
Curaleaf Enhances Offer to Acquire Aurora Cannabis
-
21st Annual Night of Hope Gala to Support Camps for Families Grieving Loss from Suicide or Overdose
-
Manulife Announces Presenting Partnership of The Hinton Lectures™ on AI Safety
-
Forward Therapeutics Announces Positive Phase 1 Data for Potential Best-in-Class Oral TNFR1 Signaling Inhibitor FT2109, Supporting Advancement into Phase 2 Development
-
Pryzm Becomes Belisar
-
Yardi unveils Virtuoso Enterprise, a complete AI platform for real estate, ahead of YASC San Diego
-
BlueWhale Bio Highlights Continued Progress Across Cell Therapy Platform and Operations
-
Snow College Awarded $3 Million Federal Grant to Lead Rural Utah's AI Future
-
MICROIP and AQLS Draw Defense, Healthcare and Energy Demand for NDAA-Compliant AI Drones at Taiwan Expo USA
-
COCO ROBOTICS AND DELIVEROO ANNOUNCE EXCLUSIVE PARTNERSHIP TO SCALE ROBOT DELIVERIES ACROSS THE UK
-
Vortex Energy Commissions Hydrogen and Helium Study at Robinsons River Salt Project
-
VantageScore CEO to Participate in Q4 2026 Financial Services Investor Conferences
